Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases

Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …

Recent advances in gold–NHC complexes with biological properties

M Mora, MC Gimeno, R Visbal - Chemical Society Reviews, 2019 - pubs.rsc.org
This tutorial review covers the recent advances made in the study of gold complexes
containing N-heterocyclic carbene ligands with biological properties. The great stability …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

[HTML][HTML] Advances in the design of organometallic anticancer complexes

P Zhang, PJ Sadler - Journal of Organometallic Chemistry, 2017 - Elsevier
Organometallic complexes containing ligands such as CO, carbenes, alkyls, phenyls, π-
bound alkynes, alkenes, cyclopentadienyls and arenes possess properties which have often …

Gold-based medicine: a paradigm shift in anti-cancer therapy?

CI Yeo, KK Ooi, ERT Tiekink - Molecules, 2018 - mdpi.com
A new era of metal-based drugs started in the 1960s, heralded by the discovery of potent
platinum-based complexes, commencing with cisplatin [(H3N) 2PtCl2], which are effective …

Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium

T Zou, CN Lok, PK Wan, ZF Zhang, SK Fung… - Current opinion in …, 2018 - Elsevier
Highlights•Metal-NHC complexes have their metal centers stabilized under physiological
conditions and can exhibit anticancer activity.•Metal-NHC complexes having new …

New insights in Au-NHCs complexes as anticancer agents

M Porchia, M Pellei, M Marinelli, F Tisato… - European journal of …, 2018 - Elsevier
Within the research field of antitumor metal-based agents alternative to platinum drugs, gold
(I/III) coordination complexes have always been in the forefront due mainly to the familiarity …

Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update

J Zhang, B Zhang, X Li, X Han, R Liu… - Medicinal research …, 2019 - Wiley Online Library
Mammalian thioredoxin reductase (TrxR) enzymes are homodimeric flavin proteins sharing
a unique yet essential selenocysteine residue at their C‐terminus. TrxRs, together with their …

The thioredoxin system: a promising target for cancer drug development

H Ghareeb, N Metanis - Chemistry–A European Journal, 2020 - Wiley Online Library
The thioredoxin system is highly conserved system found in all living cells and comprises
NADPH, thioredoxin, and thioredoxin reductase. This system plays a critical role in …

Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple …

M Zaki, S Hairat, ES Aazam - RSC advances, 2019 - pubs.rsc.org
The advent of the clinically approved drug cisplatin started a new era in the design of
metallodrugs for cancer chemotherapy. However, to date, there has not been much success …